Novartis Ag NVS
NYSE NVS
$156.26 -4.07 (-2.54%)
At close: Aug 20, 2026 · 4:00 PM EDT

Novartis Ag (NVS) EPS (Basic) Growth (3y) (2012 - 2026)

Novartis Ag (NVS) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 5.11%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 21.23%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn 38.72%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn -59.02%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 11.28%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 19.50%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -129.90%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -28.08%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn -34.06%
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn -35.71%

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.02%
Jun 30, 2025 -9.03%
Dec 31, 2024 -10.22%
Jun 30, 2024 -5.20%
Dec 31, 2023 -3.31%
Sep 30, 2023 -97.52%
Jun 30, 2023 1.92%
Mar 31, 2023 -7.96%
Dec 31, 2022 3.96%
Sep 30, 2022 27.17%
Jun 30, 2022 8.74%
Mar 31, 2022 4,030.05%
Dec 31, 2021 -3.82%
Sep 30, 2021 96.83%
Jun 30, 2021 -9.96%
Mar 31, 2021 10,252.93%
Dec 31, 2020 -7.70%
Sep 30, 2020 2,049.51%
Jun 30, 2020 203.48%
Mar 31, 2020 -50.88%